PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.\', \'School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA.\', \'Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine University of Georgia, Athens, GA, USA.\', \'Department of Infectious Diseases, College of Veterinary Medicine University of Georgia, Athens, GA, USA.\', \'Department of Biology, Georgia State University, Atlanta, GA, USA.\', \'Analytics and Data Science Institute, Kennesaw State University, Kennesaw, GA, USA.\', \'Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA. chiara@gatech.edu.\', \'Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA. philip.santangelo@bme.gatech.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41587-021-00822-w
?:doi
?:hasPublicationType
?:journal
  • Nature biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 33536629
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 18.252
?:rankingScore_hIndex
  • 377
?:title
  • Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all